Imunon, Inc.
IMNN
$6.24
-$0.11-1.73%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -43.33% | 123.02% | |||
| Gross Profit | 43.33% | -123.02% | |||
| SG&A Expenses | -22.18% | 3.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -33.23% | -0.02% | |||
| Operating Income | 33.23% | 0.02% | |||
| Income Before Tax | 33.20% | -1.12% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 33.20% | -1.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 33.20% | -1.12% | |||
| EBIT | 33.23% | 0.02% | |||
| EBITDA | 33.97% | 0.74% | |||
| EPS Basic | 49.24% | -0.87% | |||
| Normalized Basic EPS | 49.24% | -0.87% | |||
| EPS Diluted | 49.24% | -0.87% | |||
| Normalized Diluted EPS | 49.24% | -0.87% | |||
| Average Basic Shares Outstanding | 31.60% | 0.24% | |||
| Average Diluted Shares Outstanding | 31.60% | 0.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||